Christopher M. Jones

National Advisory Board Member
Director, Division of Science Policy, Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services (HHS)

• Moderator Third-Party Payer Track: Workers’ Compensation: Dangerous Prescribing Practices and At-Risk Patients
Tuesday, March 29, 2016, 2:00 pm to 3:15 pm
• Moderator Treatment Track: Closing Treatment Gaps in the Healthcare and Criminal Justice Systems
Tuesday, March 29, 2016, 3:30 pm to 4:45 pm
• Moderator PDMP Track: Linking and Mapping PDMP Data
Wednesday, March 30, 2016, 3:30 pm to 4:45 pm

Jones_Chris_lgDr. Christopher Jones serves as Director of the Division of Science Policy in the Office of the Assistant Secretary for Planning and Evaluation (ASPE) at the U.S. Department of Health and Human Services (HHS). The Division serves as the ASPE lead on public health and biomedical science issues and initiatives. Dr. Jones previously served as senior advisor in the Office of Public Health Strategy and Analysis in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA), led the CDC’s drug abuse and overdose work, and completed a one-year detail to the White House Office of National Drug Control Policy (ONDCP) as Senior Public Health Advisor. During this detail, he co-led the development of the administration’s 2011 Prescription Drug Abuse Prevention Plan. Dr. Jones previously lead the Drug Safety and Risk Communication team in the FDA’s Center for Drug Evaluation and was part of the Science Team in the CDC’s Strategic National Stockpile. Dr. Jones earned his bachelor’s degree from Reinhardt College, his pharmacy doctorate from Mercer University, and his master’s of public health from New York Medical College School of Public Health.